McAdam LLC’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,115
Closed -$226K 199
2021
Q3
$226K Buy
+4,115
New +$215K 0.03% 159
2021
Q2
Sell
-4,115
Closed -$208K 179
2021
Q1
$208K Hold
4,115
0.03% 150
2020
Q4
$245K Hold
4,115
0.04% 139
2020
Q3
$277K Sell
4,115
-7,656
-65% -$418K 0.05% 108
2020
Q2
$493K Hold
11,771
0.1% 64
2020
Q1
$371K Hold
11,771
0.1% 62
2019
Q4
$475K Buy
+11,771
New +$412K 0.11% 47

Other funds holding SILK

McAdam LLC's SILK Position: Q4 2021 in Review

McAdam LLC sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2021, closing a stake of 4,115 shares — an estimated $226K sold.

McAdam LLC first reported a position in SILK in Q4 2019 and held it in 7 quarters. The position peaked at $493K in Q2 2020. 152 funds tracked by Wall St. Rank hold SILK as of Q4 2021.

  • McAdam LLC reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • McAdam LLC sold 4,115 Silk Road Medical, Inc. Common Stock shares in Q4 2021, an estimated $226K.
  • McAdam LLC first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • McAdam LLC's Silk Road Medical, Inc. Common Stock position peaked at $493K in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2021.

Based on McAdam LLC's 13F filing for Q4 2021, filed 7 Jan 2022.